SALEM, Ore. (KTVZ) – Starting Tuesday, Oregon Health Plan (OHP / Medicaid) members will be able to get over-the-counter birth control pills, including Opill, and emergency contraception at no cost at ...

If you took the warning label that comes with your birth control and tossed it right in the trash, you wouldn’t be alone. After all, every medication comes with a risk of side effects, and those ...

What Is Aqvesme, and Why Does It Matter? Aqvesme (mitapivat) is a new oral medicine approved by the FDA for treating anemia in adults with alpha- or beta-thalassemia, including those who need and ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

The lowest doses of the daily pill will cost $149 a month for people paying out of pocket, offering a cheaper alternative to ...

Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication George Frey/Bloomberg via Getty The U.S. Food and Drug Administration has approved the pill form of Wegovy, the weight-loss ...

The U.S. Food and Drug Administration approved the Wegovy pill in late December 2025 for adults who are obese or overweight ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy, the first daily oral medication for obesity treatment. The once-daily tablet — ...

The pill version of Novo Nordisk’s weight loss treatment Wegovy received Food and Drug Administration approval Monday, marking the first oral GLP-1 medication that will soon hit the market. The ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...